As of 2024-12-15, the Intrinsic Value of Cogent Biosciences Inc (COGT) is
-10.97 USD. This COGT valuation is based on the model Peter Lynch Fair Value.
With the current market price of 8.15 USD, the upside of Cogent Biosciences Inc is
-234.57%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-10.97 USD
Intrinsic Value
COGT Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-10.97 - -10.97 |
-10.97 |
-234.57% |
| P/E |
(60.45) - (66.86) |
(59.01) |
-824.0% |
| DDM - Stable |
(18.28) - (56.24) |
(37.26) |
-557.2% |
| DDM - Multi |
(13.58) - (32.74) |
(19.23) |
-335.9% |
COGT Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
900.25 |
| Beta |
-0.61 |
| Outstanding shares (mil) |
110.46 |
| Enterprise Value (mil) |
803.20 |
| Market risk premium |
4.60% |
| Cost of Equity |
9.96% |
| Cost of Debt |
5.00% |
| WACC |
6.81% |